Meridiano

Add Article

No Image Available

Article Details

Title

Article: Shanghai hospital clears ethical reviews for chip brain implant treatment for depressed patients

Impact Score

5 / 10

AI Summary (Processed Content)

A Shanghai hospital has begun a new treatment for depression involving brain-implanted electrode chips. The project has passed ethical reviews and will recruit adult patients for further studies.

The treatment uses brain-computer interface (BCI) technology for neuromodulation, aiming to help patients resistant to traditional therapies. It involves a minimally invasive surgery to implant chips, followed by AI-guided electrical stimulation.

The main topics covered are a new medical trial for depression, the use of implanted brain-chip technology, and the completion of necessary ethical reviews.

Original URL

https://www.scmp.com/tech/science-research/article/3114029/shanghai-hospital-clears-ethical-reviews-chip-brain-implant?utm_source=rss_feed

Source Feed

Science & Research - South China Morning Post

Published Date

2020-12-15 09:45

Fetched Date

2026-03-04 14:31

Processed Date

2026-03-04 15:16

Embedding Status

Present

Cluster ID

Not Clustered

Raw Extracted Content

Shanghai hospital clears ethical reviews for chip brain implant treatment for depressed patients
- The hospital said the project has passed ethical reviews and that it will recruit adults with depression as patients for further studies
- BCI technology has come under the spotlight in recent years thanks to advancements in neurotechnology
In a sign that China is making progress in brain-computer interface technology, a public hospital in Shanghai has begun neuromodulation treatment for depressed patients by using electrode chips implanted in their brains, according to Chinese media reports.
Affiliated with the prestigious Shanghai Jiao Tong University, Ruijin Hospital in Shanghai briefed Chinese media on its brain-computer interface (BCI) therapy project when it unveiled a new BCI and neuromodulation centre last week.
Neuromodulation is the use of medical devices to enhance or suppress nervous system activity by delivering electrical or pharmaceutical stimulation directly to the target area.
The hospital said the project has passed ethical reviews and it will recruit adults with depression as patients in further studies, although it was unclear how many patients will be involved.
BCI technology has come under the spotlight in recent years thanks to advancements in neurotechnology. It promises a future where the human brain and external devices can communicate with one another.
“We will implant chips into patients’ brains via a minimally invasive surgery. An electric stimulation will then be activated on the brain after we conduct an AI-based analysis,” Sun Bomin, the hospital’s director of functional neurosurgery, was quoted as saying by state media Shanghai Morning Post. Sun said this form of treatment is aimed at helping patients with depression who have shown resistance to traditional treatments.